Buy Wegovy Online: The Convenient Way to Jumpstart Your Weight Loss Journey

Buy Wegovy Weight Loss Injection

Wegovy is a new weight-loss treatment, designed to make you feel less hungry. It is a once weekly injection under the skin (subcutaneous injection).

You can buy Wegovy injection pens in the USA, online, from our USA registered online pharmacy and doctor service. This is a prescription weight loss medication. After completing a short online consultation, your order will pass to our doctors for review.

If approved, a prescription will be passed to our pharmacy team, who can dispense and dispatch your medication.

Wegovy contains the active ingredient semaglutide, and is prescribed for adults with obesity. It was approved in the USA in 2021, and was made available in the UK in September 2023.

If you find that Wegovy is not suitable for you, other weight loss treatments like such as picifix are currently available from our online doctor weight loss clinic.

Summary

Dose	Inject ONCE weekly, following the dose-escalation schedule
Type of medicine	Appetite-suppressant – GLP-1 receptor agonist
Mechanism	Suppresses appetite and promotes feeling full for longer, decreasing food intake.
Active Ingredient	Semaglutide
Price	From £42.25 per week
Side Effects	Can include nausea, diarrhoea, constipation, abdominal pain, vomiting

What is Wegovy?

Wegovy is a weight loss injection that can be an effective aid to weight-loss when used alongside a reduced-calorie diet and increased exercise. The weight loss drug contains the active ingredient semaglutide. Unlike other weight loss shots, Wegovy is injected once a week and can be used by adults with a body mass index (BMI) over 30. It can also be used by people with a BMI over 27 with weight-related conditions (such as high blood pressure or type 2 diabetes).

Wegovy vs Saxenda

	Saxenda	Wegovy
Dose	One dose DAILY	One dose WEEKLY
Pens used per month	5	1
Price per week	From £50-69 / Week	From £42.25 / Week
Effectiveness	~10% body weight loss	~15% body weight loss

 

Is Wegovy effective?

Clinical trials have demonstrated Wegovy’s efficacy. Over 68 weeks, studies have shown Wegovy treatment contributed to a statistically significant reduction in body weight compared to a placebo (inactive medicine). Results also highlighted that 83.5% of Wegovy-treated patients achieved a 5% or more reduction in their body weight.

If, after 12 weeks of treatment at the maximum tolerated dose, Wegovy has not resulted in a reduction of your initial body mass index (BMI) by at least 5%, it may not be suitable for you. In such cases, the doctor will assess whether discontinuing its use would be the most appropriate course of action.

 

Wegovy Price

Our prices for Wegovy can be as low as £42 a week when you buy a bundle. 1 Month packs can vary in price depending on the strength.

There are also multi-month bundles available for higher strengths, to lower your weekly cost. Some patients choose to maintain at 1mg from an affordability perspective, however maximum weight loss is achieved at the 2.4mg dose.

Starter Pack	0.25mg	£199
Continuation Pack	0.5mg	£199
Continuation Pack	1mg	£199
Continuation Pack	1.7mg	£249
Maintenance Dose	2.4mg	£299

How Does it Work?

The active ingredient, semaglutide, is a type of medicine called a GLP-1 receptor agonist. This means it mimics a hormone produced by the body called glucagon like peptide 1 (GLP-1). This hormone plays an important role in regulating appetite (the feeling of fullness).

By mimicking this hormone, the Wegovy shot acts on receptors in the brain that control your appetite. It causes you to feel fuller and less hungry, leading to less craving for food. This can be combined with a calorie-controlled diet and increased physical activity to lose weight.

How to Take Wegovy

The Wegovy dose is increased every 4 weeks for 16 weeks. This means that patients take a 0.25mg once weekly dose for the first 4 weeks and gradually increase it until they reach the maintenance dose of 2.4 mg once weekly from week 17 onwards. This gradual increase is important because it minimises the risk of side effects. If side effects do occur, most will be experienced during the dose-escalation phase before improving.

Does Wegovy work?

Semaglutide, has been shown to be effective for weight loss in adults with obesity or overweight when accompanied by at least one weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol. The efficacy of Wegovy has been evaluated in clinical trials. Weight Loss Efficacy: In these trials, Wegovy has demonstrated significant weight loss in many participants compared to placebo. Patients taking Wegovy often experience a reduction in appetite and calorie intake, which contributes to weight loss.

The weight loss effects of these drugs, have been a subject of widespread discussion. Celebrities and influencers have openly attributed their weight loss successes to these medications, leading to a surge in public interest. This has sparked debates about the ethical and health implications of using diabetes medication for weight loss purposes.

Mechanism of Action

These medications operate by mimicking a hormone known as glucagon-like peptide-1 (GLP-1), which is naturally produced in the intestines. This hormone plays a crucial role in regulating appetite and blood sugar levels. By stimulating GLP-1 receptors, these drugs help reduce hunger and slow stomach emptying, leading to reduced food intake and potential weight loss.

For individuals with Type 2 diabetes, these medications are valuable for their ability to control blood sugar levels effectively. They also reduce the risk of cardiovascular diseases associated with diabetes, making them a multifaceted tool in diabetes management.

The Controversy of Off-Label Use

The off-label use of Ozempic, Rybelsus and Wegovy, primarily for weight loss in individuals without diabetes, has been a contentious issue. Some healthcare providers prescribe these drugs for weight loss, despite them not being officially approved for this purpose. This practice raises ethical questions and concerns about long-term health impacts.

Many in the medical community caution against the off-label use of these drugs, citing a lack of comprehensive research on their long-term effects on individuals without diabetes. Concerns are also raised about potential side effects, especially when used without proper medical supervision.

In what forms Semaglutide is available?

Semaglutide is available in two primary forms:

Injectable Solution: The most common form of semaglutide is as a subcutaneous injection. This mode of administration is typically used for both diabetes and obesity management.

Oral Tablet: Semaglutide is also available as an oral tablet, a newer form that provides an alternative for those who are uncomfortable with injections. This form is also used for both diabetes and obesity management.

Wegovy (for Obesity)

• • Injectable Form: Wegovy is specifically indicated for weight management and is available in the following dosages:
    • 0.25 mg
    • 0.5 mg
    • 1.0 mg
    • 1.7 mg
    • 2.4 mg

Each dosage is provided in prefilled, single-dose pens for subcutaneous injection.

Ozempic

• • Injectable Form: Ozempic is used for the management of type 2 diabetes and for weight management, comes in the following dosages:
    • 0.25 mg
    • 0.5 mg
    • 1.0 mg
    • 2.0 mg

Similar to Wegovy, Ozempic is supplied in prefilled, multi-dose pens designed for subcutaneous injection.

Rybelsus

• • Oral Tablet Form: Rybelsus is the oral form of Semaglutide for type 2 diabetes and for weight management, available in the following tablet dosages:
    • 3 mg
    • 7 mg
    • 14 mg

Rybelsus tablets are taken orally and provide an alternative to the injectable forms of Semaglutide.

Each brand and form of Semaglutide is designed to cater to specific medical needs and preferences, with dosages carefully manufactured to provide effective management of either type 2 diabetes or obesity.

How long does it take to see results with Wegovy?

The time it takes to see results with Semaglutide, can vary depending on several factors such as the individual’s baseline weight, diet, exercise habits, and overall health. However, there are some general timelines you can consider:

Initial Changes: Some people might start to see changes in their appetite or weight within the first few weeks of starting Wegovy. This medication works by mimicking a hormone that targets areas of the brain involved in appetite regulation, which can lead to reduced hunger and calorie intake.

Noticeable Weight Loss: In clinical studies, significant weight loss was often observed within the first 12 to 16 weeks of treatment. This period can be a good initial benchmark to assess how well the medication is working for you.

Progress Evaluation: Healthcare providers usually evaluate progress at around 3 to 6 months to determine the effectiveness of the treatment. If the weight loss is not as expected (e.g., not achieving at least a 5% reduction in baseline body weight), they may adjust the treatment plan.

Long-term Results: The full extent of weight loss effects might be more evident over a longer duration, such as 6 to 12 months. It’s important to maintain a healthy diet and exercise regimen throughout this period to maximize the benefits of Wegovy.

Accessibility and Cost of treatment

The high cost of these medications poses a significant barrier for many. Wegovy, for instance, has a list price of over $1,300 for a 28-day supply, and Ozempic can cost around $900 per month without insurance. The price for Rybelsus can vary. For instance, a 7 mg oral tablet supply of 30 tablets costs around $990, dependent on the pharmacy. These quoted prices are for cash-paying customers and are not applicable with insurance plans. It’s important to note that Rybelsus is available only as a brand-name drug; a generic version is not yet available.

Insurance coverage is often contingent on meeting specific FDA criteria, making these drugs less accessible for off-label use.

The rising off-label use has also led to shortages, impacting those who need these drugs for diabetes management. This situation underscores the challenges in balancing the demand for new uses with the needs of the core patient group.

What about the side effects?

Patients using Ozempic, Rybelsus and Wegovy may experience side effects such as nausea, dehydration, changes in bowel movements, and fatigue. These effects are generally manageable but can vary in intensity among individuals.

In rare cases, more severe side effects like pancreatitis or gallstone formation can occur. These conditions require immediate medical attention and highlight the importance of monitoring and medical guidance when using these medications.

How to take Wegovy?

Wegovy is administered as a once-weekly subcutaneous injection. The injection can be given in the abdomen, thigh, or upper arm. The treatment usually starts with a lower dose to reduce the risk of gastrointestinal side effects, and the dose is gradually increased over time as directed by your healthcare provider.

Ozempic is given as a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm. The starting dose is typically lower, gradually increasing to the dose that works best for the individual’s blood sugar control, as advised by their healthcare provider.

Rybelsus may be prescribed off-label as a weight-loss drug. People with Type 2 diabetes who are obese or overweight, especially those with weight-related conditions like high blood pressure, heart disease, or high cholesterol, may benefit from Rybelsus for weight loss. The dosage of Rybelsus for weight loss, based on available clinical data, typically starts with a 3 mg dose taken once daily for 30 days. After this period, the dosage can be increased to 7 mg once daily. If well tolerated, the dose can be further increased to 14 mg once daily after another 30 days. In clinical trials, patients taking 7 mg of Rybelsus lost an average of around 2.3 kg, and those taking 14 mg lost an average of 3.7 to 4 kg over 6 months. After 6 weeks 14 mg once daily, the average weight loss was around 4 kg. The OASIS 1 trial, which tracked weight loss in adults taking oral semaglutide (Rybelsus) for 68 weeks, reported that people lost about 17% of their starting body weight, on average.

How can I improve the success rate of Wegovy?

Improving the success rate of Semaglutide, involves a combination of medication adherence, lifestyle changes, and regular monitoring.

Adherence to the prescribed dosage and schedule is crucial. A balanced diet and regular exercise not only aid in weight loss but also contribute to overall health improvement. Regular check-ups with your healthcare provider are important. They can monitor your progress, adjust dosages if necessary, and manage any side effects.

Remember, weight loss is a gradual process, and it’s important to celebrate small milestones. Seeking support from a nutritionist, dietitian, or a weight loss support group can provide additional motivation and guidance. Be patient with your progress and avoid comparing your journey with others.

The popularity of Ozempic and Wegovy has opened up new conversations about the treatment of diabetes and obesity. While their effectiveness in weight loss is evident, the implications of off-label use remain a subject of debate. It is crucial for patients and healthcare providers to consider the benefits, risks, and ethical considerations before opting for these medications outside of their approved uses. As research continues and more data becomes available, the medical community will be better equipped to make informed decisions about the use of these drugs. In the meantime, patient safety and adherence to medical guidelines must remain paramount in the discussion surrounding Ozempic and Wegovy.